The present study was conducted to assess the relationship between metabolic syndrome and systolic inter-arm blood pressure difference (sIAD) in Korean adults.
Methods:
This study included 410 adults (235 males, 175 females) who were over 30 years old and had undergone a health check from July to December in 2013.
Results:
The incidence of high sIAD and metabolic syndrome were 23.4% and 23.2%, respectively. Key study results were as follows: First, the sIAD levels increased significantly with an increase in metabolic syndrome score (p<0.001), shown by sIAD levels after adjusted the variables that affect sIAD levels (age, gender, smoking, drinking, exercising, total cholesterol, and body mass index). These were 4.6±0.7 mmHg for metabolic syndrome score (MSS) 0; 5.8±0.5 mmHg for MSS 1; 6.2±0.6 mmHg for MSS 2, 9.2±0.8 mmHg for MSS 3; and 9.9±1.2 mmHg for MSS ≥4 (p<0.001). Second, the sIAD level of the metabolic syndrome group (9.3±0.7 mmHg) was significantly higher (p<0.001) than for the nonmetabolic syndrome group (5.7±0.3 mmHg).
Conclusions:
In conclusion, metabolic syndrome and an increased number of its components are associated with the sIAD levels in Korean adults.
Get full access to this article
View all access options for this article.
References
1.
KwonHS, ParkYM, LeeHJ, et al.The prevalence and clinical characteristics of the metabolic syndrome in Korean adults. Korean J Intern Med, 2005; 20:310–316.
2.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001; 285:2486–2497.
3.
IsomaaB, AlmgrenP, TorsenB, et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001; 24:683–689.
4.
McNeillAM, RosamondWD, GirmanCK, et al.The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care, 2005; 28:385–390.
5.
WhayneTFJr.Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review. Int J Angiol, 2010; 19:e96–e99.
6.
ChangSN. An analytic An analytic comparison of risk factors for peripheral artery disease, coronary artery disease, and normal control: A case-control study. M.Sc. thesis, Seoul, Korea: The University of Seoul; 2010.
7.
GrundySM, CleemanJL, DanielsSR, et al.American Heart Association; National Heart, Lung, and Blood Institute, Diagnosis and management of the metabolic syndrome: An American Heart Association/ational Heart, Lung, and Blood Institude Scientific Statement. Circulation, 2002; 112:2735–2752.
8.
AmsterdamB, AmsterdamAL. Disparity in blood pressures in both arms in normals and hypertensives and its clinical significance. NY State J Med, 1943; 43:2294–2300.
KimJ, SongTJ, SongD. Interarm blood pressure difference and mortality in patients with acute ischemic stroke. Neurology, 2013; 80:1457–1464.
11.
CassidyP, JonesK. A study of interarm blood pressure differences in primary care. J Hum Hypertens, 2001; 15:519–522.
12.
ClarkCE, CampbellJL, PowellRJ. The interarm blood pressure difference as predictor of cardiovascular events in patients with hypertension in primary care: Cohort study. J Hum Hypertens, 2007; 21:633–638.
ClarkCE, TaylorRS, ShoreAC, CampbellJL. The difference in blood pressure readings between arms and survival: Primary care cohort study. BMJ, 2012; 344:e1327.
15.
ZhangZ, MaJ, TaoX, et al.The prevalence and influence factors of inter-ankle systolic blood pressure difference in community population. PLoS One, 2013; 8:e70777.
16.
CanepaM, MilaneschiY, AmeriP, et al.Relationship between inter-Arm difference in systolic blood pressure and arterial stiffness in community dwelling older adults. J Clinical Hypertens, 2013; 15:880–887.
17.
KimKB, OhMK, KimHG, et al.Inter-arm differences in simultaneous blood pressure measurements in ambulatory patients without cardiovascular diseases. Korean J Fam Med, 2013; 34:98–106.
18.
WhiteJ, MortensenLH, KivimäkiM, GaleCR, BattyGD. Interarm differences in systolic blood pressure and mortality among US army veterans: Aetiological associations and risk prediction in the Vietnam experience study. Eur J Prev Cardiol, 2014; 21:1394–1400.
19.
SuHM, LinTH, HsuPC, et al.Association of interarm systolic blood pressure difference with atherosclerosis and left ventricular hypertrophy. PLoS One, 2012; 7:e41173.
20.
ChoiSM, KimKY, LeeTY, JungJG, LeeOK. Incidence and related factors of the metabolic syndrome in a university hospital. Korean J Health Educ Promot, 2009; 26:35–47.
21.
SeoJA. Metabolic syndrome and associated risk factors among the clients of a comprehensive medical examination center. J East-West Nurs Res, 2008; 14:47–53.
22.
LeeEH, ChoS, KwonEJ, et al.Prevalence and related factors of metabolic syndrome among Korean older adults. Korean J Health Educ Promot, 2009; 26:129–143.
23.
FriedewaldWT, LevyRI, FredricksonDS. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18:499–502.
24.
KobalavaAD, KotovskayaYV, BabaevaLA, MoiseevVS. Validation of TM-2655 oscillometric device for blood pressure measurement. Blood Press Monit, 2006; 11:87–90.
25.
World Health Organization; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and its Treatment, Sydney, Australia: Health Communication Australia Pty, Ltd., 2000: 15–21.
26.
FordES, GilesWH, DietzWH. Prevalence of metabolic syndrome among US adults. JAMA, 2002; 287:356–359.
27.
MoonJY, ParkSG, AhnCM, et al.Increase of metabolic syndrome score is an independent determinant of increasing pulse pressure. Yonsei Med J, 2008; 49:63–70. doi: 10.3349/ymj.2008.49.1.63.
28.
WangJ, RuotsalainenS, MoilanenL, LepistöP, LaaksoM, KuusistoJ. The metabolic syndrome predicts incident stroke: A 14-year follow-up in elderly people in Finland. Stroke, 2008; 39:1078–1083.
29.
DekkerJM, GirmanC, RhodesT, et al.Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation, 2005; 112:666–673.
30.
ClarkCE, CampbellJL, EvansPH, MillwardA. Prevalence and clinical implications of the inter-arm blood pressure difference: A systematic review. J Hum Hypertens, 2006; 20:923–931.
31.
WeinbergI, GonaP, O'DonnellCJ, JaffMR, MurabitoJM. The systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study. Am J Med, 2014; 127:209–215.
32.
ClarkCE, CampbellJL, PowellRJ, ThompsonJF. The inter-arm blood pressure difference and peripheral vascular disease: Cross-sectional study. Fam Pract, 2007; 24:420–426.
33.
ClarkCE. Difference in blood pressure between arms might reflect peripheral vascular disease. BMJ, 2001; 323:399–400.
34.
NguyenLL. Percutaneous treatment of peripheral vascular disease: The role of diabetes and inflammation. J Vasc Surg, 2007; Supply 45:149–157.
35.
KimuraA, HashimotoJ, WatabeD, et al.Patient characteristics and factors associated with inter-arm difference of blood pressure measurements in a general population in Ohasama, Japan. J Hypertens, 2004; 22:2277–2283.
36.
LilitkarntakulP, DhaunN, MelvilleV, et al.Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity. Diabetes Care, 2012; 35:1774–1780.
37.
MalikS, WongND, FranklinSS, et al.Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and on all causes in United States adults. Circulation, 2004; 110:1245–1250.
38.
YouMA, SonYJ. Prevalence of metabolic syndrome and associated risk factors among Korean adolescents analysis from the Korean National Survey. Asia Pac J Public Health, 2012; 24:464–471.
39.
KohBR, KimYK, AhnSM, et al.Relationship between diabetic peripheral vascular disease and ankle-brachial index. J Korean Endocr Soc, 2006; 21:382–388.
